- Service Name
FUJIFILM Diosynth Biotechnologies
- Industry
Biotechnology, Contract Development and Manufacturing Organization (CDMO), Biologics, Advanced Therapies
- Main Value Proposition
FUJIFILM Diosynth Biotechnologies offers a reliable partnership for the development and manufacturing of life-impacting medicines, ensuring quality and compliance throughout the process.
- Description
FUJIFILM Diosynth Biotechnologies is a contract development and manufacturing organization (CDMO) that specializes in the development and commercial supply of biologics, vaccines, and advanced therapies. The company provides end-to-end support from preclinical development through to commercialization, ensuring life-impacting medicines reach patients globally.
- Key Features
End-to-end support for biologics and advanced therapies; cGMP manufacturing capabilities; Expertise in cell line and strain development; Comprehensive CMC and regulatory services
- Use Cases
The service is most valuable in scenarios such as drug development for clinical trials, scaling up production for commercialization, and providing regulatory support for submissions.
- Competitive advantages
World-class cGMP manufacturing facilities; Strong technical leadership in cell culture and microbial fermentation; Comprehensive support throughout the drug development lifecycle
- Strengths
Key strengths include a robust investment in infrastructure, a diverse range of services from preclinical to commercial stages, and a commitment to quality and regulatory compliance.
- Positioning
FUJIFILM Diosynth Biotechnologies positions itself as a leading CDMO that combines technical expertise with a commitment to quality, catering to the needs of the life sciences industry.
- Audience
The target users include pharmaceutical companies, biotech firms, and research institutions looking for reliable CDMO partners for biologics and advanced therapies.
- CTA
Learn More About Us
- Tags
CDMO
Biologics
Advanced Therapies
cGMP Manufacturing
- Tagline
Partners for Life
- Tone of Voice
Professional, supportive, innovative
- Differentiation
The company stands out in the market due to its extensive global facilities, significant investments in advanced manufacturing technologies, and a strong commitment to quality and innovation in biologics and advanced therapies.
- Brand Positioning
The brand identity emphasizes partnership, reliability, and innovation, aiming to be a trusted ally in the development of life-saving medicines.
- Founded
2011-01-01
- Founders
Martin Meeson